eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
 
6/2009
vol. 47
 
Share:
Share:
more
 
 
abstract:
Review paper

Should every rheumatoid arthritis patient receive statin therapy?

Robert Rupiński
,
Ewa Walewska
,
Rafał Dąbrowski
,
Ewa Kaliszuk-Kamińska
,
Anna Filipowicz-Sosnowska

Reumatologia 2009; 47, 6: 348-355
Online publish date: 2010/04/08
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The clinical and laboratory link between impaired lipid metabolism or atherosclerosis and chronic inflammation in rheumatoid arthritis (RA) has been established over the past decade. Cardiovascular diseases (CVD) are currently considered as the main cause of mortality in RA. This unfavourable tendency could be reversed by systematic evaluation of cardio-metabolic risk factors, tight control of RA activity, standard preventive activities and implementation of statins. National guidelines of lipid-lowering therapy and clinical data concerning RA as a potential risk factor of CVD should be taken into account in the planning of statin therapy.
keywords:

statins, rheumatoid arthritis, cardiovascular diseases



Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe